↓ Skip to main content

SGLT-2 inhibitors on prognosis and health-related quality of life in patients with heart failure and preserved ejection fraction: A systematic review and meta-analysis

Overview of attention for article published in Frontiers in Cardiovascular Medicine, September 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SGLT-2 inhibitors on prognosis and health-related quality of life in patients with heart failure and preserved ejection fraction: A systematic review and meta-analysis
Published in
Frontiers in Cardiovascular Medicine, September 2022
DOI 10.3389/fcvm.2022.942125
Pubmed ID
Authors

Danning Yang, Yu Zhang, Jie Yan, Ming Liu, Fengshuang An

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 17%
Student > Doctoral Student 2 9%
Student > Postgraduate 2 9%
Student > Master 2 9%
Other 1 4%
Other 0 0%
Unknown 12 52%
Readers by discipline Count As %
Medicine and Dentistry 5 22%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Environmental Science 1 4%
Mathematics 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Other 0 0%
Unknown 14 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2022.
All research outputs
#18,805,293
of 23,305,591 outputs
Outputs from Frontiers in Cardiovascular Medicine
#3,373
of 7,205 outputs
Outputs of similar age
#301,998
of 435,566 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#440
of 1,059 outputs
Altmetric has tracked 23,305,591 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,205 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,566 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,059 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.